BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33229221)

  • 21. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.
    Ogino S; Odze RD; Kawasaki T; Brahmandam M; Kirkner GJ; Laird PW; Loda M; Fuchs CS
    Am J Surg Pathol; 2006 Sep; 30(9):1175-83. PubMed ID: 16931963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.
    Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
    Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
    Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.
    Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
    Neoplasia; 2007 Dec; 9(12):1091-8. PubMed ID: 18084616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Ogino S; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS
    Int J Cancer; 2008 Jun; 122(12):2767-73. PubMed ID: 18366060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.
    Samowitz WS; Curtin K; Wolff RK; Albertsen H; Sweeney C; Caan BJ; Ulrich CM; Potter JD; Slattery ML
    Genes Chromosomes Cancer; 2008 Oct; 47(10):835-44. PubMed ID: 18615680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.
    Weisenberger DJ; Levine AJ; Long TI; Buchanan DD; Walters R; Clendenning M; Rosty C; Joshi AD; Stern MC; LeMarchand L; Lindor NM; Daftary D; Gallinger S; Selander T; Bapat B; Newcomb PA; Campbell PT; Casey G; Ahnen DJ; Baron JA; Haile RW; Hopper JL; Young JP; Laird PW; Siegmund KD;
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):512-519. PubMed ID: 25587051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    Neoplasia; 2006 Jun; 8(6):458-64. PubMed ID: 16820091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS
    Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR
    Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
    Jia M; Jansen L; Walter V; Tagscherer K; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Br J Cancer; 2016 Nov; 115(11):1359-1366. PubMed ID: 27811854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
    Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
    Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and identification of factors related to
    Lin L; Chen GY; Xu CW; Wang HY; Wu YF; Fang MY
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C191-C198. PubMed ID: 28230016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.
    Cheng YW; Pincas H; Bacolod MD; Schemmann G; Giardina SF; Huang J; Barral S; Idrees K; Khan SA; Zeng Z; Rosenberg S; Notterman DA; Ott J; Paty P; Barany F
    Clin Cancer Res; 2008 Oct; 14(19):6005-13. PubMed ID: 18829479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.